{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:33:44Z","timestamp":1789947224111,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.clml.2015.08.084","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T10:42:03Z","timestamp":1441276923000},"page":"785-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Role of \u03b2-Catenin in Bcr\/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study"],"prefix":"10.1016","volume":"15","author":[{"given":"Ayfer","family":"Geduk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif B.","family":"Atesoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Tarkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mehtap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Hacihanefioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra T.","family":"Demirsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Baydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2015.08.084_bib1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2015.08.084_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jcmm.12033","article-title":"Pharmacological modulation of beta-catenin and its applications in cancer therapy","volume":"17","author":"Thakur","year":"2013","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.clml.2015.08.084_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ceb.2008.01.009","article-title":"Wnt\/\u03b2-catenin signaling: new (and old) players and new insights","volume":"20","author":"Huang","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.clml.2015.08.084_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0959-437X(99)80003-3","article-title":"The oncogenic activation of beta-catenin","volume":"9","author":"Polakis","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.clml.2015.08.084_bib5","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1073\/pnas.0305855101","article-title":"Illegitimate WNT signaling promotes proliferation of multiple myeloma cells","volume":"101","author":"Derksen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clml.2015.08.084_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1471-2407-12-213","article-title":"Concurrent epigenetic silencing of wnt\/\u03b2-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia","volume":"12","author":"Moskalev","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2015.08.084_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/leu.2011.17","article-title":"Heterogeneous sensitivity of human acute myeloid leukemia to \u03b2-catenin down-modulation","volume":"25","author":"Gandillet","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2015.08.084_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2407-12-303","article-title":"Wnt\/\u03b2-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia","volume":"12","author":"Corr\u00eaa","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2015.08.084_bib9","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"10.1016\/j.clml.2015.08.084_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2141.2004.05049.x","article-title":"Aberrant expression of \u03b2-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia","volume":"126","author":"Serins\u00f6z","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2015.08.084_bib11","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.humpath.2008.02.007","article-title":"The role of \u03b2-catenin in chronic myeloproliferative disorders","volume":"39","author":"Jauregui","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clml.2015.08.084_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/asheducation-2006.1.233","article-title":"Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders","volume":"510","author":"Levine","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2015.08.084_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcb.22714","article-title":"Blockade of JAK2 activity suppressed accumulation of \u03b2-catenin in leukemic cells","volume":"111","author":"Liu","year":"2010","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.clml.2015.08.084_bib14","first-page":"131","article-title":"Infrequent hypermethylation of WIF-1 promoter in BCR\/ABL-negative myeloproliferative disorders","volume":"32","author":"Suzuki","year":"2007","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.clml.2015.08.084_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11655-014-1810-x","article-title":"Inhibitory effect of cryptotanshinone on angiogenesis and Wnt\/\u03b2-catenin signaling pathway in human umbilical vein endothelial cells","volume":"20","author":"Chen","year":"2014","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.clml.2015.08.084_bib16","first-page":"25","article-title":"Evaluation of angiogenesis in idiopathic myelofibrosis with CD31 and CD34 by light microscope and computer-aided image analysis system","volume":"8","author":"Al-Mudallal","year":"2010","journal-title":"Iraqi J Med Sci"},{"key":"10.1016\/j.clml.2015.08.084_bib17","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1080\/10428190400003267","article-title":"Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia","volume":"45","author":"Arora","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2015.08.084_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/01.RES.0000253533.65446.33","article-title":"Regulation of smooth muscle cell proliferation by \u03b2-catenin\/T-cell factor signaling involves modulation of cyclin D1 and p21 expression","volume":"99","author":"Quasnichka","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.clml.2015.08.084_bib19","first-page":"887","article-title":"Targeting the Wnt\/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model","volume":"25","author":"Kim","year":"2011","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.clml.2015.08.084_bib20","first-page":"325","article-title":"Increased in\u00a0vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid","volume":"25","author":"Schmidt","year":"2011","journal-title":"In\u00a0Vivo"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265015012422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265015012422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:25Z","timestamp":1761870385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265015012422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2152265015012422"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2015.08.084","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of \u03b2-Catenin in Bcr\/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2015.08.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}